Back to search

Article

Comparative Immune profiling in Pancreatic Ductal Adenocarcinoma Progression Among South African patients

2023-10-23

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Introduction</h4> Pancreatic Ductal Adenocarcinoma (PDAC) is an aggressive cancer with a 5-year survival rate of only 11%. PDAC is characterized by an immunosuppressive microenvironment; thus, there have been multiple attempts to target it, although with little success. A better understanding of the immune landscape in PDAC is required to help elucidate the roles of these cells for effective...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a6f15597-28dc-5eea-b4b5-a334aebb462f
DOI
10.1101/2023.10.23.23297385
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Comparative Immune profiling in Pancreatic Ductal Adenocarcinoma Progression Among South African patientsDOI 10.1101/2023.10.23.23297385
Select a neighboring publication to make it the new centre.